Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.
Research Interests

Papers共 397 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Combination of Encorafenib and Binimetinib Followed by Ipilimumab and Nivolumab Versus Ipilimumab and Nivolumab in Patients with Advanced Melanoma with BRAFV600E or BRAFV600K Mutations (EBIN): an International, Open-Label, Randomised, Controlled, Phase 2 Study
Caroline Robert, Michal Kicinski,Caroline Dutriaux,Émilie Routier, Anne-Sophie Govaerts, Emanuel Bührer,Eve-Marie Neidhardt,Xavier Durando, Barouyr Baroudjian,Philippe Saiag, Caroline Gaudy-Marqueste,Paolo A Ascierto, Ana Arance,Michelangelo Russillo,Jean-Luc Perrot,Laurent Mortier,Francois Aubin,Stéphane Dalle,Florent Grange, Eva Muñoz-Couselo, Sorilla Mary-Prey, Mona Amini-Adle,Sandrine Mansard,Céleste Lebbe, Elisa Funck-Brentano, Sandrine Monestier, M, Felix Oppong, Leen Wijnen, Bastian Schilling, Mario MandalÁ, Paul Lorigan, Alexander C J van Akkooi
The Lancet Oncologyno. 6 (2025): 781-794
Cited0Views0WOSBibtex
0
0
3MO LDH Isoforms Shape the Immune Microenvironment and Impact Treatment Response and Survival in Metastatic Melanoma
L. Soumoy, V. Quidville, C. Sarre-Pradon, L. Lacroix,E. Routier, H. Hermann, S. Roy,N. Benannoune,S. Vagner, F. Chehade,B. Archambaud,C. Robert
Immuno-Oncology and Technology (2024): 100887
Cited0Views0Bibtex
0
0
Load More
Author Statistics

#Papers: 396

#Citation: 6876

H-Index: 30

G-Index: 81

Sociability: 7

Diversity: 3

Activity: 47

  • 合作者
  • 学生
  • 导师
No result temporarily, you can search similar Scholar with the same research interest
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn